Financial Ratios

VERONICA LABORATORIES LTD.

NSE : NABSE : 524802ISIN CODE : INE994A01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.520 (0 %)
PREV CLOSE ( ) 3.52
OPEN PRICE ( ) 3.52
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )3.34 3.52
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2003Mar2002Mar2001Mar2000Mar1999
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.690.200.281.780.26
   CEPS(Rs)-0.130.671.102.960.55
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)11.4313.9113.6013.0911.73
   Tax Rate(%)0.007.156.837.900.00
Margin Ratios
   Core EBITDA Margin(%)-0.071.377.8014.6811.25
   EBIT Margin(%)-1.151.593.7010.458.39
   Pre Tax Margin(%)-2.420.921.527.433.30
   PAT Margin (%)-2.420.861.416.853.30
   Cash Profit Margin (%)-0.452.885.5911.347.06
Performance Ratios
   ROA(%)-4.121.051.489.241.59
   ROE(%)-5.491.442.0914.382.49
   ROCE(%)-2.302.184.2917.785.21
   Asset Turnover(x)1.701.221.051.350.48
   Sales/Fixed Asset(x)4.452.812.394.091.75
   Working Capital/Sales(x)3.052.251.752.680.81
Efficiency Ratios
   Fixed Capital/Sales(x)0.220.360.420.240.57
   Receivable days108.98141.01154.44121.21350.83
   Inventory Days20.4322.7322.4215.4852.17
   Payable days21.3116.4619.0056.15183.11
Valuation Parameters
   PER(x)0.0034.9850.3028.9649.55
   PCE(x)-32.8210.3912.7017.4823.21
   Price/Book(x)0.360.501.033.951.09
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.170.410.822.071.93
   EV/Core EBITDA(x)20.3311.3610.4413.8115.89
   EV/EBIT(x)-14.6225.7722.2419.7523.00
   EV/CE(x)0.320.510.852.910.75
   M Cap / Sales0.150.300.711.981.64
Growth Ratio
   Net Sales Growth(%)24.8818.01-24.37233.4547.92
   Core EBITDA Growth(%)-71.50-45.86-60.14311.1273.92
   EBIT Growth(%)-189.91-49.16-73.24316.06196.86
   PAT Growth(%)-453.21-28.60-84.40591.56243.02
   EPS Growth(%)-445.76-28.60-84.40590.51161.42
Financial Stability Ratios
   Total Debt/Equity(x)0.060.200.200.200.20
   Current Ratio(x)5.117.8312.1811.082.71
   Quick Ratio(x)4.386.7910.879.952.51
   Interest Cover(x)-0.902.371.693.461.65
   Total Debt/Mcap(x)0.170.390.190.050.18

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.